Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2025-09-16
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 EFFECTDeclared effective9999999995-25-002969
2025-03-04
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 424B5Shelf takedown0001558370-25-002173
2023-05-05
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 EFFECTDeclared effective9999999995-23-001320
2023-03-30
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 S-3Shelf registered0001558370-23-005145
2021-02-18
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 424B5Shelf takedown0001047469-21-000388
2021-02-17
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 424B5Shelf takedown0001047469-21-000369
2019-10-31
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 424B5Shelf takedown0001047469-19-005986
2019-10-29
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 424B5Shelf takedown0001047469-19-005954
2019-10-15
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 EFFECTDeclared effective9999999995-19-002314
2019-10-01
Y-mAbs Therapeutics, Inc.
ShelfEffectiveCIK 1722964
 S-3Shelf registered0001558370-19-008756
2018-09-24
Y-mAbs Therapeutics, Inc.
IPOFinal prospectusCIK 1722964
 424B4Final prospectus0001047469-18-006346
2018-09-20
Y-mAbs Therapeutics, Inc.
IPOFinal prospectusCIK 1722964
 EFFECTDeclared effective9999999995-18-002420
2018-09-07
Y-mAbs Therapeutics, Inc.
IPOFinal prospectusCIK 1722964
 S-1/AAmendment0001047469-18-006039
2018-08-24
Y-mAbs Therapeutics, Inc.
IPOFinal prospectusCIK 1722964
 S-1Registration filed0001047469-18-005786
2018-02-13
Y-mAbs Therapeutics, Inc.
CIK 1722964
 DRSDraft made public0000912057-18-000071